Susan Champion

Title: Susan Champion: Innovator in Synthetic Analogues

Introduction

Susan Champion is a distinguished inventor based in Chesham, GB. She has made significant contributions to the field of synthetic analogues, holding a total of four patents. Her work focuses on developing compounds that have important applications in medical diagnostics and therapies.

Latest Patents

One of her latest patents involves labelled glutamine and lysine analogues. These synthetic analogues of lysine and glutamine serve as substrates for the fibrin-stabilising enzyme Factor XIIIa, even when labelled with a detectable moiety. The use of suitable protecting groups allows for compounds that exhibit reduced susceptibility to in vivo metabolism, particularly by peptidases. This makes them valuable agents for diagnosing conditions such as thrombosis, embolism, atherosclerosis, inflammation, or cancer. Another notable patent is related to labelled Factor XIIIa substrates. This patent describes a complex of a radiometal or paramagnetic metal ion with a metal chelating agent, which can function as a substrate for the fibrin-stabilizing Factor XIIIa. This complex is also useful for diagnosing or treating thrombosis, embolism, atherosclerosis, inflammation, or cancer.

Career Highlights

Throughout her career, Susan has worked with prominent companies such as Amersham Plc and Nycomed Amersham Plc. Her innovative work has positioned her as a key figure in the development of medical diagnostic tools.

Collaborations

Susan has collaborated with notable professionals in her field, including Anthony Eamon Storey and Marivi Mendizabal. These collaborations have further enhanced her research and contributions to synthetic analogues.

Conclusion

Susan Champion's work in synthetic analogues has made a significant impact on medical diagnostics and therapies. Her innovative patents and collaborations highlight her role as a leading inventor in her field.